Bell Investment Advisors Inc decreased its holdings in The Clorox Company (NYSE:CLX – Free Report) by 35.1% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 433 shares of the company’s stock after selling 234 shares during the quarter. Bell Investment Advisors Inc’s holdings in Clorox were worth $71,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Prospera Private Wealth LLC bought a new stake in Clorox in the third quarter valued at $27,000. Innealta Capital LLC acquired a new stake in shares of Clorox in the 2nd quarter valued at $30,000. Trifecta Capital Advisors LLC increased its position in shares of Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after purchasing an additional 130 shares in the last quarter. Quarry LP lifted its holdings in Clorox by 99.1% during the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after purchasing an additional 114 shares during the last quarter. Finally, Family Firm Inc. acquired a new position in Clorox in the second quarter valued at about $31,000. 78.53% of the stock is owned by institutional investors.
Insider Buying and Selling at Clorox
In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the transaction, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. The trade was a 11.40 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.57% of the company’s stock.
Clorox Trading Down 0.2 %
Clorox (NYSE:CLX – Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm’s revenue was up 27.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.49 earnings per share. On average, research analysts expect that The Clorox Company will post 6.85 EPS for the current fiscal year.
Clorox Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 2.92%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio is currently 170.04%.
Wall Street Analysts Forecast Growth
CLX has been the subject of a number of research analyst reports. Citigroup lifted their target price on shares of Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and boosted their price objective for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. Evercore ISI lowered their target price on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research note on Monday, October 14th. DA Davidson upped their price target on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. Finally, BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a research report on Friday, September 6th. Five investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $155.00.
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
See Also
- Five stocks we like better than Clorox
- Insider Buying Explained: What Investors Need to Know
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- How to Use the MarketBeat Stock Screener
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Trading Halts Explained
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.